Background: Leishmaniasis is a major global health problem which affects millions of people, especially in the developing countries. The incidence of leishmaniasis has increased and there is no vaccination for Leishmania infections and standard drugs for treatment of the disease have many side effects; therefore, it is necessary to find new effective alternatives. Objectives: The purpose of this study was to evaluate the in vitro antileishmanial activity of Ixora brachiata root extract against Leishmania major and Leishmania infantum promastigotes. Materials and Methods: Different doses of the selected plant extract was tested against L. major and L. infantum promastigotes using colorimetric MTT [3-(4, 5-methylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] assay. Glucantime was used as the positive control. Results: Anti-parasitic activity was revealed for I. brachiata root on L. major and L. infantum with 50% inhibitory concentration (IC 50 ) values of 0.91 and 2.63 µg/mL, respectively compared to the standard drugs, glucantime, which had an IC 50 value of 40.2 µg/mL for L. major and 18.5 µg/ mL for L. infantum after 72 hours.
Background
Leishmaniasis, a parasitic disease caused by parasites of the genus Leishmania, is a major worldwide health problem that menaces about 350 million people, with almost 2 million new cases reported annually. 1 It is endemic in 80 countries. The disease has 3 manifestations: visceral, mucocutaneous or cutaneous leishmaniasis; the most severe form is the visceral leishmaniasis caused by Leishmania donovani and Leishmania infantum with approximately 500 000 new cases reported annually. 1 Cutaneous leishmaniasis is a parasitic disease that has affected 98 countries and regions around the world and 90 % of cutaneous leishmaniasis cases occur in Afghanistan, Algeria, Brazil, Iran, Peru, Saudi Arabia, and Syria. 1, 2 Herbal medicine is a beneficial remedy as an alternative drug for treatment of infectious diseases, due to lower costs and scanty side effects. Therefore, a number of studies have been done to investigate the anti-leishmanial activity of medicinal herbs. [3] [4] [5] [6] A few researchers reported that herbal medicine can be used as an adjuvant in vaccination against Leishmania spp. 7 Recent studies showed that the extracts of Peganum harmala and Hedera helix have potent antileishmanial activity. 8, 9 Moreover, the anti-leishmanial activity of Juglans regia and Lawsonia inermis were shown in another study. 10 Ixora brachiata Roxb. is a genus of the flowering plants from the family Rubiaceae, consisting of tropical evergreens and shrubs. It is a small evergreen tree, about 6-10 feet in height. It has elliptic-oblong leaves which are about 20 cm long and 7.5 cm wide, which is usually used in India for skin diseases by traditional medicine practitioners. 11 Flowers are white ( Figure 1 ) and found to be growing in high rainfall locality. 12 Ixora plant and its various parts like flowers, leaves, roots, barks, and fruits have been used by various racial groups of Africa, Asia and Europ. 13 In folklore medicine, Ixora is recognized to be useful for many illnesses such as cancer, hepatic disorder, pain, microbial infection, antioxidant, inflammation, and so on. The genus Ixora has been reported to possess different compounds like triterpenoids (lupeol, ursolic acid, oleanolic acid, betunolic acid, amyrins, etc), aromatic acrid oils, tannins, saponins, carbohydrate, fatty acids, flavonoids (rutin, formononetin, β-sitosterol, quercetin and kaempferol), and sterols. 14 Previous researches reported the antileish manicidal activity of the flavonoids from Con solida oliveriana and the efficacy of the carbohydrates in the treatment of leishmaniasis. In addition, tannins isolated from Anogeissus leiocarpus was shown to possess a good activity against Leishmania. 15 In the last decades, sesquiterpene lactone (STL) and triterpenes isolated from Asteraceae. This family have been reported as having trypanocidal and leishmanicidal activities. 16 Therefore, natural products are effective for the treatment of important tropical diseases caused by protozoans such as leishmaniasis. The novelty of this study is that the anti-parasitic activities of this plant have been studied for the first time.
Materials and Methods

Plant Material
Ixora brachiata was collected from Ratnagiri, Maharashtra State, India. The plant parts were identified by Research Center for Botanical Sciences in India (RCBSI) and voucher specimens were deposited in the herbarium of Botany University of Pune, India, with voucher numbers of RCBSI-PU-007.
Extract Preparation
For preparation of hydroalcoholic extracts, 10 g of shadedried and powdered plant material was macerated in 100 ml ethanol (85%) solution on a rotary shaker for 72 hours. The plant extracts were filtered through Whatman No. 1 and kept at room temperature until evaporation. 17 Dried extracts were obtained and stored at 4°C for further assays. The Cell Proliferation Elisa by Colorimetric MTT Assay MTT [3-(4, 5-methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay measured conversion of MTT dye (tetrazolium) into formazan by mitochondrial enzymes in viable cells. The test was done according to the procedure described previously. [18] [19] [20] Briefly, 100 μL aliquots of promastigotes (1×10 6 ) at logarithmic phase were grown in various concentrations of Ixora brachiata root extract (0.61-156 mg mL -1 w/v) in 96-well micro-plate. Then, 20 μL MTT reagent (Sigma Chemical Company) was added to a final concentration of 400 μg mL -1 per well, and the microplate was incubated for 3 hours at 24°C. The cells were centrifuged for 10 minutes and 100 μL DMSO (dimethyl sulfoxide, Sigma Co.) was added to micro-plate and incubated for 15 minutes. The optical density (OD) at 540 nm was measured using an ELISA plate reader (Convergys EL-Reader, Convergent Technologies, Germany). The results were represented as the concentration of different extracts that inhibited parasite growth by 50% (IC 50 ).
Antileishmanial and Cytotoxicity Assays
Statistical Analysis
The data were analyzed by SPSS version 22.0 using one-way ANOVA test. The results were defined as the mean values of at least three experiments ± SD by linear regression. P values less than 0.05 were considered significant.
Results
In the present study, anti-parasitic activity of the root extract of I. brachiata was determined using MTT assay. Fifty percent inhibitory concentration (IC 50 ) values for the root extract of Ixora brachiata at 24, 48, and 72 hours for L. major were 3.1, 1.61, and 0.91 µg/mL and for L. infantum, the values were 17.5, 4.32, and 2.63 µg/ mL, respectively, whereas these values for glucantime at 24, 48, and 72 hours for L. major were reported to be 104.45, 61.4, and 40.2 µg/mL and for L. infantum, the values were 99.7, 45.6, and 18.5 µg/mL, respectively. The findings demonstrated that the root extract of Ixora brachiata had potent an tileishmanial activity against L. major and L. infantum promastigotes after 24, 48, and 72 hours of incubation (P < 0.05). These results also revealed that the root extract of Ixora brachiata had significantly (P < 0.05) higher leishmanicidal ef fect on the promastigotes of L. major and L. infantum in comparison with glucantime since it exhibited lower IC 50 values for the tested promastigotes. The effect of the root extract of Ixora brachiata in different concentrations on the parasite has been shown in Tables 1, 2 and Figure 1 . Additionally, glucantime revealed IC 50 values of 40.2 and 18.5 μg/mL against promastigotes of L. major and L. infantum after 72 hours of incubation.
Discussion
Antimony compounds are still the first choice for treatment of leishmaniasis; however, due to their toxic effects, long duration of therapy and progression of drug resistance, they have been considered unsatisfactory. 21 On the other hand, herbal medicines are rich sources of antileishmanial drugs with a shorter treatment duration. They are safe, cheaper and partly available in endemic countries. [22] [23] [24] [25] Therefore, the research on the antileishmanial effects of medicinal plants is urgently essential. In this study, the antileishmanial effects of the ethanolic extracts of Ixora brachiata root on L. major and L. infantum promastigotes were evaluated by MTT assay. The results of this study revealed that I. brachiata root extract possess antileishmanial properties against L. major and L. infantum Promastigotes. Previous research reported that I. brachiata root extract revealed the best activity against L. major Promastigotes with IC 100 value of 2.5 mg/mL and IC 50 value of 0.078 mg/mL. 17 Another researcher investigated the antileishmanial activity of another species of Ixora such as Ixora coccinea leaf against L. donovani promastigotes by in vitro promastigote cell toxicity assay by using MTT [3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide] and reported that this plant inhibited the growth of L. donovani promastigotes. 26 Moreover, other researchers reported that the bark extract of I. brachiata inhibited the growth of Staphylococcus 11 and the root extract of I. brachiata showed antidermatophytic activity. 27 Antimicrobial activity of the methanolic extract of Ixora species against bacteria such as Bacillus cereus, B. megaterium, B. subtilis, Staphylococcus aureus, Sarcina lutea, Escherichia coli, Pseudomonas aeruginosa, Salmonella paratyphi, S. typhi, Shigella boydii, S. dysenteriae, Vibrio mimicus, and V. parahaemolyticus and fungi like Candida albicans, Aspergillus niger, and Saccharomyces cerevisiae showed a broad-spectrum of antibacterial and anti-yeast activities. 28 I. brachiata root extract gave positive test results for triterpenes and coumarin by HPTLC (highperformance thin-layer chromatography) in another study. 27 Moreover, the presence of compounds such as tan nins, flavonoids, saponin carbohydrates, coumarins, and triterpenes reported by previous studies, 17 may be responsible for leishmanicidal activity in this plant. These results are in line with the observations of previous researchers, [29] [30] who have shown the anti-leishmanicidal activity of the flavonoids isolated from Con solida oliveriana and the efficacy of the carbohydrates in treatment of leishmaniasis. In addition, tannins isolated from Anogeissus leiocarpus was shown to possess a good activity against Leishmani. 15 Other compounds such as terpenoids (sesquiterpene lactones) have been reported to be active against Leishmania. 16 The toxicological activity of this extract should also be investigated to ensure the safety of this herbal medicine in the future.
Conclusion
The evaluation of side effects of I. brachiata root extract on host cells in animals and humans is necessary. 
